Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
HHS-OIG Highlights Anti-Fraud Safeguards Of Refund, Discount Program Offered By Pharma To Alleviate Drug's Cost https://t.co/wVCtOrzLm1 #Drugs #Health #Crime @LaurenWeberHP https://t.co/GRVRWQ6DTv
Drug Channels News Roundup, July 2024: - My $0.02 on the FTC's #PBM report - @GoodRx joins the #Humira #biosimilar price war - Averon #GPO = @CVSHealth + @CardinalHealth - Why #IRA = Bad news for #340B #hospitals ==> https://t.co/3r1Izle9Ww
Unraveling Fraud Like a Double Helix: Two Whistleblowers Receive Over $860,000 for Reporting Genetic Testing Kickbacks https://t.co/01kQhaSVWc #Criminal #Health #Whistle @modrnhealthcr https://t.co/fe2teIbBGv
A U.S. judge in Manhattan has confirmed that there were 'robust' safeguards in place to prevent fraudulent claims in a $30 million settlement involving Novartis. This settlement arose from several class actions where thousands of improper claims were detected. The judge's comments came during a review of the claims process, emphasizing the measures designed to protect against fraud in the distribution of the settlement funds.